NCT02035280

Brief Summary

As the population continues to age, the prevalence of spinal deformity surgery for older patients is increasing. Questions regarding the suitability of these patients to undergo large spinal procedures and whether the outcomes merit the risks involved are not well known.

Trial Health

93
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
233

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2013

Longer than P75 for all trials

Geographic Reach
8 countries

13 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2013

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

December 19, 2013

Completed
26 days until next milestone

First Posted

Study publicly available on registry

January 14, 2014

Completed
7.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

July 28, 2023

Status Verified

July 1, 2023

Enrollment Period

8 years

First QC Date

December 19, 2013

Last Update Submit

July 27, 2023

Conditions

Keywords

SpineDeformityFusionElderlySRS-22r

Outcome Measures

Primary Outcomes (1)

  • Absolute change in the Scoliosis Research Society-22 r (SRS-22r) total score

    The primary outcome is the absolute change in the SRS-22r total score between baseline and 24-months follow-up (FU) values in patients at age 60 or older treated with major spinal reconstruction. The SRS-22r is a patient-reported outcome instrument and has a range from 1 (worst) to 5 (best). It contains 22 questions covering five domains: function, pain, self-image, mental health (each with 5 items), and satisfaction with treatment (2 items) and each item is scored from 1 to 5.

    Baseline, 10 weeks, 12 months, 24 months

Secondary Outcomes (8)

  • Treatment-related adverse events

    Surgery, 10 weeks, 12 months, 24 months, 5 years

  • Oswestry Disability Index Version 2.1a (ODI)

    Baseline, 10 weeks, 12 months, 24 months, 5 years

  • EuroQoL5 (EQ-5D).

    Baseline, 10 weeks, 12 months, 24 months, 5 years

  • Pain (back and pain)

    Baseline, 10 weeks, 12 months, 24 months, 5 years

  • Bone Mineral Density (BMD)

    Baseline

  • +3 more secondary outcomes

Study Arms (1)

Elderly suffering of spine deformity

Spinal deformity patients over the age of 60 years undergoing elective surgery and requiring fusion of at least 5 levels.

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Elderly patients undergoing elective surgery for spinal deformity

You may qualify if:

  • Age 60 years or older at the time of surgery
  • Diagnosis of adult spinal deformity either in the coronal or sagittal plane requiring at the minimum a 5-level spinal fusion procedure
  • Ability to understand the content of the patient information / Informed Consent Form
  • Willingness and ability to participate in the clinical investigation according to the Clinical Investigation Plan (CIP)
  • Signed and dated Institutional Review Board (IRB)/Ethics Committee (EC)-approved written informed consent
  • Reconsent of patients for the 5 year follow-up if required by the IRB/EC

You may not qualify if:

  • Any previous spinal procedure (except prior decompression of a maximum of 2 levels)
  • Neurodegenerative disease or paralysis
  • Unlikely to comply with follow-up
  • Institutionalized individuals
  • Any not medically managed severe systemic disease
  • Recent history (≤ 3 months) of substance abuse (ie, recreational drugs, alcohol) or psychosocial disturbance that would preclude reliable assessment
  • Prisoner
  • Presence of active malignancy
  • Has active, overt bacterial infection, systemic or local
  • History of recent(≤ 3 months) fracture/malignancy in the spinal region
  • Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (13)

UCSF Medical Center

San Francisco, California, 94118, United States

Location

University of Minnesota

Minneapolis, Minnesota, 55454, United States

Location

Washington University Orthopedics

St Louis, Missouri, 63110, United States

Location

New York Presbyterian - Columbia University Medical Center

New York, New York, 10032, United States

Location

University of Virginia

Charlottesville, Virginia, 22903, United States

Location

Toronto Western Hospital

Toronto, Ontario, Canada

Location

Queen Mary Hospital

Hong Kong, China

Location

Nanjing University Medical School

Nanjing, China

Location

Rigshospitalet

Copenhagen, Denmark

Location

Hamamatsu University School of Medicine

Hamamatsu, Japan

Location

St. Maartens Kliniek

Nijmegen, Netherlands

Location

Hospital Vall d'Hebron

Barcelona, Spain

Location

Aciboden Maser Hospital

Istanbul, Turkey (Türkiye)

Location

Related Publications (1)

  • Campos Daziano M, Daunt L, Vashishth V, Seider E, Abbas A, Rienmueller A, Matsuyama Y, Qiu Y, Kelly M, Smith JS, Dahl BT, Spruit M, de Kleuver M, Polly DW, Sembrano J, Pellise-Urquiza F, Cheung KMC, Alanay A, Lenke LG, Shaffrey CI, Berven SH, Lewis SJ; PEEDS Study Group and AO Spine Knowledge Forum Deformity. Can Social Function Improve in Older Patients Undergoing Multi-Level Spinal Deformity Surgery? Global Spine J. 2025 Dec 27:21925682251411237. doi: 10.1177/21925682251411237. Online ahead of print.

MeSH Terms

Conditions

Congenital Abnormalities

Condition Hierarchy (Ancestors)

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Stephen Lewis, MD

    University of Toronto

    PRINCIPAL INVESTIGATOR
  • Sigurd Berven, MD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 19, 2013

First Posted

January 14, 2014

Study Start

December 1, 2013

Primary Completion

December 1, 2021

Study Completion

December 1, 2022

Last Updated

July 28, 2023

Record last verified: 2023-07

Locations